Analgesic Drug Combinations in Neuropathic Pain (2004)
- Conditions
- europathic painNervous System DiseasesNeuropathic pain
- Registration Number
- ISRCTN73178636
- Lead Sponsor
- Canadian Institutes of Health Research (CIHR) (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 71
1. Diabetic patients of either sex
2. 18 to 89 years of age
3. Distal, symmetric, sensory polyneuropathy
1. Neuropathy attributable to an etiology other than diabetes (e.g. hypothyroidism, vitamin B12 deficiency, connective tissue disease, amyloidosis and toxic exposure)
2. Presence of a painful condition as severe as, but distinct from, their diabetic neuropathy pain
3. Pregnancy or lactation
4. End-stage kidney or liver disease
5. Moderate to severe heart disease (Myocardial Infarction [MI] within preceding year, unstable angina, cardiac conduction defect or congestive heart failure)
6. Cardiovascular autonomic neuropathy
7. Postural hypotension more than 20 mmHg on initial assessment
8. Baseline mild to severe sedation or ataxia due to required concomitant drugs, or any other cause
9. Males with urinary symptoms attributable to benign prostatic hypertrophy
10. Presence of a seizure disorder
11. Angle-closure glaucoma
12. Ongoing administration of Monoamine Oxidase (MAO) inhibitors and/or a serious psychiatric disorder as diagnosed by a psychiatrist
13. Ongoing administration of anticonvulsants which induce cytochrome P450 enzymes (e.g. carbamazepine, oxcarbazepine)
14. Hypersensitivity to any of the study medications
15. History of significant abuse of illicit drugs, prescription drugs or alcohol
16. Lack of a primary physician
17. Patients who live alone and cannot assure daily contact with a friend, family member or caregiver
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.